Tuberous sclerosis medical therapy: Difference between revisions
Jump to navigation
Jump to search
Jose Loyola (talk | contribs) No edit summary |
Jose Loyola (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
{{Tuberous sclerosis}} | {{Tuberous sclerosis}} | ||
{{CMG}} | {{CMG}} | ||
== Overview == | |||
Medical therapy is generally preferred over surgical ones due to their fewer number of complications and diminishing side effects over time. | |||
==Medical Therapy== | ==Medical Therapy== | ||
| Line 7: | Line 10: | ||
=== Epilepsy === | === Epilepsy === | ||
* Anti-[[seizure]] medications can be prescribed to control [[seizures]]. The preferred medication is [[vigabatrin]]<ref name="pmid19557123">{{cite journal |author=Tsao CY |title=Current trends in the treatment of infantile spasms |journal=Neuropsychiatr Dis Treat |volume=5 |issue= |pages=289–99 |year=2009 |pmid=19557123 |pmc=2695218 |doi= |url=http://www.dovepress.com/articles.php?article_id=3150}}</ref>, but other [[anticonvulsants]], [[clobazam]], [[Ketogenic diet|ketogenic]] diet, | * Anti-[[seizure]] medications can be prescribed to control [[seizures]]. The preferred medication is [[vigabatrin]]<ref name="pmid19557123">{{cite journal |author=Tsao CY |title=Current trends in the treatment of infantile spasms |journal=Neuropsychiatr Dis Treat |volume=5 |issue= |pages=289–99 |year=2009 |pmid=19557123 |pmc=2695218 |doi= |url=http://www.dovepress.com/articles.php?article_id=3150}}</ref>, but other [[anticonvulsants]], [[clobazam]], [[Ketogenic diet|ketogenic]] diet, or surgical procedures.<ref name=":0">Henske, Elizabeth P., et al. "Tuberous sclerosis complex." ''Nature reviews Disease primers'' 2.1 (2016): 1-18.</ref> Treatment before the onset of [[epilepsy]] and other neuropsychiatric manifestations may be beneficial, but trials testing this approach are still ongoing (EPISTOP trial). [[mTOR]] inhibitors may present with some anti-epileptogenic properties.<ref name=":0" /> | ||
=== Lymphangioleiomyomatosis === | === Lymphangioleiomyomatosis === | ||
| Line 15: | Line 18: | ||
=== Angiomyolipoma === | === Angiomyolipoma === | ||
* Treatment is done in a pre-emptive manner to prevent bleeding, reduce tumor size or slow its growth. | * Treatment is done in a pre-emptive manner to prevent bleeding, reduce tumor size or slow its growth. Systemic [[everolimus]] is the preferred method nowadays but there are also surgical options. <ref name=":0" /> | ||
=== Subependymal Giant Cell Astrocytoma === | === Subependymal Giant Cell Astrocytoma === | ||
* | * Treatment with [[mTOR]] inhibitors have been recommended, being well tolerated and presenting with side effects that decreases over time.<ref name=":0" /> There are also surgical procedures but they have important complications. | ||
=== Tuberous Sclerosis Complex-associated Neuropsychiatric Disorder === | === Tuberous Sclerosis Complex-associated Neuropsychiatric Disorder === | ||
| Line 29: | Line 32: | ||
* [[Sunscreen|Sun protection]]; | * [[Sunscreen|Sun protection]]; | ||
* "Camouflage make-up" | * "Camouflage make-up" | ||
* Topical mTOR inhibitors. | * Topical mTOR inhibitors. | ||
*There are surgical options and ablation. | |||
=== mTOR Inhibitors side effect: === | === mTOR Inhibitors side effect: === | ||
Revision as of 23:30, 19 June 2020
|
Tuberous sclerosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tuberous sclerosis medical therapy On the Web |
|
American Roentgen Ray Society Images of Tuberous sclerosis medical therapy |
|
Risk calculators and risk factors for Tuberous sclerosis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical therapy is generally preferred over surgical ones due to their fewer number of complications and diminishing side effects over time.
Medical Therapy
Epilepsy
- Anti-seizure medications can be prescribed to control seizures. The preferred medication is vigabatrin[1], but other anticonvulsants, clobazam, ketogenic diet, or surgical procedures.[2] Treatment before the onset of epilepsy and other neuropsychiatric manifestations may be beneficial, but trials testing this approach are still ongoing (EPISTOP trial). mTOR inhibitors may present with some anti-epileptogenic properties.[2]
Lymphangioleiomyomatosis
- Sirolimus should be used in women presenting with TSC-associated lymphangioleiomyomatosis or sporadic LAM with <70% of the predicted normal FEV1. Everolimus has also been show to improve these patients' condition.[2]
Angiomyolipoma
- Treatment is done in a pre-emptive manner to prevent bleeding, reduce tumor size or slow its growth. Systemic everolimus is the preferred method nowadays but there are also surgical options. [2]
Subependymal Giant Cell Astrocytoma
- Treatment with mTOR inhibitors have been recommended, being well tolerated and presenting with side effects that decreases over time.[2] There are also surgical procedures but they have important complications.
Tuberous Sclerosis Complex-associated Neuropsychiatric Disorder
- There are no specific interventions, patients must be followed closely by a psychiatrist. Trials exploring the use of mTOR inhibitors for this manifestation are ongoing.[2]
Skin Lesions
For TSC-associated skin lesions, the following treatments may be performed:
- Sun protection;
- "Camouflage make-up"
- Topical mTOR inhibitors.
- There are surgical options and ablation.
mTOR Inhibitors side effect:
mTOR inhibition therapy may cause stomatitis, diabetes, hyperlipidemia, wound-healing complications, infertility and delayed sexual maturation.[2]